RT Book, Section
A1 Fitzgerald, Paul A.
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1184697360
T1 Thyroid Cancer
T2 Current Medical Diagnosis & Treatment 2022
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264269389
LK accessmedicine.mhmedical.com/content.aspx?aid=1184697360
RD 2023/06/02
AB Key  Clinical  Updates  in  Thyroid  CancerIn  patients  with  BRAFV600E  mutant  anaplastic  thyroid  cancer,  combined  BRAF  and  MEK  inhibition  with  dabrafenib  and  trametinib  has  induced  durable  responses.